Loading
NYSEReal EstateREIT - Residential
Latest quote
$19.50
−$0.68 · -3.37%
NexPoint Residential Trust (NXRT) is a Real Estate Investment Trust publicly traded on the New York Stock Exchange, specializing in the acquisition, ownership, and operation of well-located apartment communities designed for middle-income residents. The company seeks properties offering opportunities for value enhancement in major metropolitan areas and their surrounding suburbs, predominantly situated in the Southeastern and Southwestern United States. NXRT receives external advisory services from NexPoint Real Estate Advisors, L.P., an associate of NexPoint Advisors, L.P., an investment advisor registered with the SEC that possesses extensive experience in the real estate sector.
Previous close
$19.50
−$0.68 · -3.37%
After-hours
$19.50
$0.00 · 0.00%
Oct 7, 5:32 PM ET
Regular session · ET · Market data may be delayed.
NexPoint Residential Trust (NXRT) is a Real Estate Investment Trust publicly traded on the New York Stock Exchange, specializing in the acquisition, ownership, and operation of well-located apartment communities designed for middle-income residents. The company seeks properties offering opportunities for value enhancement in major metropolitan areas and their surrounding suburbs, predominantly situated in the Southeastern and Southwestern United States. NXRT receives external advisory services from NexPoint Real Estate Advisors, L.P., an associate of NexPoint Advisors, L.P., an investment advisor registered with the SEC that possesses extensive experience in the real estate sector.
Day range
Current $19.50
52-week range
Current $19.50
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
71
Undervalued
Sentiment
56
Mixed
Risk
41
Elevated Risk
Momentum
32
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
NexPoint Residential Trust (NXRT) is a Real Estate Investment Trust publicly traded on the New York Stock Exchange, specializing in the acquisition, ownership, and operation of well-located apartment communities designed for middle-income residents. The company seeks properties offering opportunities for value enhancement in major metropolitan areas and their surrounding suburbs, predominantly situated in the Southeastern and Southwestern United States. NXRT receives external advisory services from NexPoint Real Estate Advisors, L.P., an associate of NexPoint Advisors, L.P., an investment advisor registered with the SEC that possesses extensive experience in the real estate sector.
Day range
Current $19.50
52-week range
Current $19.50
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 251.28M USD | 259.7M USD | 277.53M USD | 263.95M USD | 219.24M USD |
| Cost of goods sold | 39.56M USD | 113.23M USD | 119.94M USD | 120.07M USD | 102.19M USD |
| Gross profit | 211.72M USD | 146.48M USD | 157.58M USD | 143.89M USD | 117.05M USD |
| Selling, general, and administrative | 24.89M USD | 19.4M USD | 17.15M USD | 14.67M USD | 11.97M USD |
| Operating expenses | 183.79M USD | 62.92M USD | 44.41M USD | 97.63M USD | 52.63M USD |
| Interest income | — | −3.36M USD | — | — | — |
| Interest expense | 60.74M USD | 104.12M USD | 113.34M USD | 50.59M USD | 29.6M USD |
| Depreciation and amortization | 95.75M USD | 97.76M USD | 95.19M USD | 97.65M USD | 86.88M USD |
| Operating income | 27.93M USD | 83.56M USD | 113.18M USD | 46.25M USD | 64.42M USD |
| Net income | −32.03M USD | 1.11M USD | 44.26M USD | −9.26M USD | 23.04M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Cash distributions grouped by calendar year; partial years are marked.
$2.06
2025 complete year+46.7% since 2021
2026 partial: $1.59
$1.4038
2,021
$1.56
2,022
$1.7224
2,023
$1.8973
2,024
$2.06
2,025
$1.59
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Sep 15, 2026 | $0.53Quarterly | Sep 15, 2026 | Sep 30, 2026 |
Dividend | Jun 15, 2026 | $0.53Quarterly | Jun 15, 2026 | Jun 30, 2026 |
Dividend | Mar 13, 2026 | $0.53Quarterly | Mar 13, 2026 | Mar 31, 2026 |
Dividend | Dec 15, 2025 | $0.53Quarterly | Dec 15, 2025 | Dec 31, 2025 |
Dividend | Sep 15, 2025 | $0.51Quarterly | Sep 15, 2025 | Sep 30, 2025 |
Dividend | Jun 16, 2025 | $0.51Quarterly | Jun 16, 2025 | Jun 30, 2025 |
Ex-dividend Sep 15, 2026
$0.53
Quarterly
Record Sep 15, 2026 · Payment Sep 30, 2026
Ex-dividend Jun 15, 2026
$0.53
Quarterly
Record Jun 15, 2026 · Payment Jun 30, 2026
Ex-dividend Mar 13, 2026
$0.53
Quarterly
Record Mar 13, 2026 · Payment Mar 31, 2026
Ex-dividend Dec 15, 2025
$0.53
Quarterly
Record Dec 15, 2025 · Payment Dec 31, 2025
Ex-dividend Sep 15, 2025
$0.51
Quarterly
Record Sep 15, 2025 · Payment Sep 30, 2025
Ex-dividend Jun 16, 2025
$0.51
Quarterly
Record Jun 16, 2025 · Payment Jun 30, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Real Estate ETFVNQ17.04M0.02%70.8B USD0.13%$88.69-1.38%
Vanguard Morningstar Total Stock Market ETFVTI16.29M0.00%2.3T USD0.03%$381.03-0.40%
Invesco KBW Premium Yield Equity REIT ETFKBWY12.53M4.30%291.56M USD0.35%$16.32-0.85%
iShares Russell 2000 ETFIWM11.98M0.02%78.56B USD0.19%$277.7-1.29%
Vanguard Extended Market ETFVXF6.11M0.01%95.4B USD0.05%$233.49-1.56%
Schwab U.S. REIT ETFSCHH3.37M0.03%10.52B USD0.07%$21.75-1.41%
Vanguard Russell 2000 ETFVTWO3.13M0.02%18B USD0.06%$112.21-1.26%
DFA Real Estate Securities Portfolio ETF Class SharesDFAR2.64M0.03%8B USD0.22%$23.96-1.24%Vanguard Real Estate ETFVNQVanguard Morningstar Total Stock Market ETFVTIInvesco KBW Premium Yield Equity REIT ETFKBWYiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFSchwab U.S. REIT ETFSCHHVanguard Russell 2000 ETFVTWODFA Real Estate Securities Portfolio ETF Class SharesDFARAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
